Drone deliveries are shaping up to be the future of shipping, so naturally the race is on to see which service can most quickly utilize this relatively new technology to create more seamless and efficient delivery experiences.
It looks like we might have a winner.
Researchers Figured Out How Doctors Can Make People Healthier While Saving Billions in Health Care Costs, and It's Been In Front of Our Noses This Whole Time
"Eat plenty of fruits and vegetables" has been common advice for centuries, but soon it may be doctor's orders.
Researchers are calling for access to prescriptions for fruits and vegetables to prevent common ailments, rather than treating these ailments with medications after they've already shown symptoms. A new simulation by health professionals is bolstering this evidence.
Genetic testing company 23andMe has just gotten FDA approval to sell a test for hereditary colorectal cancer syndrome directly to their consumers.
The test examines three genetic variants of Ashkenazi Jewish ancestry that have indicated a correlation to the cancer syndrome. It's the second time that 23andMe has been approved for a cancer test based on genetic mutations, with the first being a test for the BRCA gene which can act as a litmus test for the likelihood of developing breast cancer.
The former head of Insys Therapeutics will plead guilty for his part in bribing doctors to prescribe a powerful opioid in an effort to increase the drug's sales.
Federal prosecutors in Boston revealed that Michael Babich will plead guilty to conspiracy and mail fraud.
There are few times when anyone is actually glad to come upon a scorpion. With loathsome pincers and painful venom, the creatures are widely regarded as terrifying and sometimes even deadly.
But in the case of the Deathstalker scorpion, its venom is proving to be quite useful—so useful that it's become the most expensive liquid on the planet.
Breakthrough Gene Therapy Thought to Be an Effective Treatment for Some Kinds of Cancers Just Turned Deadly
Immunotherapy represents a whole new approach for combating several types of human cancers. The tactic involves scientists genetically reprogramming the cells of a person’s immune system to target and attack malignancies. Immunotherapy is now considered the “fifth pillar” of cancer treatments, rapidly evolving into a more promising tool for battling cancer than standard radiation and chemotherapeutic treatments.
Although there are many different immunotherapies in development and practice, chimeric antigen receptor T-cells (CAR-T) therapy has shown the most promise to date. Indeed, CAR-T therapy is the first anti-cancer gene therapy to be approved by the United States Food and Drug Administration (FDA) for use against advanced adult lymphomas and childhood acute lymphoblastic leukemia. Unfortunately, just recently, a patient given CAR-T therapy for aggressive leukemia died as result of the treatment.
Mysterious New Condition That Causes Paralysis In Children Has Experts Stumped, and Incidents Are On The Rise
The headlines began in 2014: Formerly healthy children contracted what seemed to be a minor upper respiratory infection and were suddenly paralyzed — sometimes one limb, sometimes multiple limbs, sometimes permanently.
Parents and experts wondered if it could be a brand-new virus, West Nile disease, or even a mutated version of polio, which hadn’t been seen in the U.S. since the late 1970s.